The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 05, 2020
Filed:
Oct. 30, 2018
Applicant:
Enzo Therapeutics, Inc., New York, NY (US);
Inventors:
Assignee:
Enzo Therapeutics, Inc., Farmingdale, NY (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/739 (2006.01); A61K 31/7004 (2006.01); A61K 31/7028 (2006.01); A61K 31/7032 (2006.01); A61K 31/00 (2006.01); A61K 35/15 (2015.01); A61K 35/17 (2015.01); A61K 31/70 (2006.01); A61K 38/17 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/739 (2013.01); A61K 31/00 (2013.01); A61K 31/70 (2013.01); A61K 31/7004 (2013.01); A61K 31/7028 (2013.01); A61K 31/7032 (2013.01); A61K 35/15 (2013.01); A61K 35/17 (2013.01); A61K 38/1709 (2013.01); A61K 38/00 (2013.01);
Abstract
The present invention provides a method for the treatment of immune mediated or immune related diseases or disorders, infectious diseases, metabolic disorders and cancer in mammalian subjects. This method comprises the administration of a naturally occurring, mammalian intermediary metabolite or T cell receptor ligand, preferably a glucosylceramide, to a mammalian subject. In a preferred embodiment, such mammalian subjects are human beings.